Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein

Molecular Pharmaceutics

Volumn 9, Issue 4, 2012, Pages 946-956

  Raghuwanshi, Dharmendra ^a   Mishra, Vivek ^a   Das, Dipankar ^a   Kaur, Kamaljit ^a   Suresh, Mavanur R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

bifunctional fusion protein; chitosan nanoparticles; DEC 205 receptor; dendritic cells; low dose vaccines

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; CHITOSAN; DEC 205 RECEPTOR; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LECTIN RECEPTOR; NANOCARRIER; NUCLEOCAPSID PROTEIN; PLASMID DNA; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; STREPTAVIDIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; BIOTINYLATION; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DNA IMMUNIZATION; DRUG FORMULATION; FEMALE; GENE TARGETING; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; SEVERE ACUTE RESPIRATORY SYNDROME;

ANIMALS; CHITOSAN; DENDRITIC CELLS; FEMALE; IMMUNITY, HUMORAL; MICE; MICE, INBRED BALB C; NANOPARTICLES; NUCLEOCAPSID PROTEINS; SARS VIRUS; VACCINES, DNA; VIRAL VACCINES;

EID: 84859328852     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp200553x     Document Type: Article

References (43)

1. Steinman, R. M. Dendritic cells in vivo: A key target for a new vaccine science Immunity 2008, 29 (3) 319-324
2. Tacken, P. J.; De Vries, I. J. M.; Torensma, R.; Figdor, C. G. Dendritic-cell immunotherapy: From ex vivo loading to in vivo targeting Nat. Rev. Immunol. 2007, 7 (10) 790-802 (Pubitemid 47480309)
3. Keler, T.; He, L.; Ramakrishna, V.; Champion, B. Antibody-targeted vaccines Oncogene 2007, 26 (25) 3758-3767 (Pubitemid 46842710)
4. Proudfoot, O.; Apostolopoulos, V.; Pietersz, G. A. Receptor-mediated delivery of antigens to dendritic cells: Anticancer applications Mol. Pharmaceutics 2007, 4 (1) 58-72
5. Inaba, I.; Swiggard, W. J.; Inaba, M.; Meltzer, J.; Mirza, A.; Sasagawa, T.; Nussenzweig, M. C.; Steinman, R. M. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145 I. Expression on dendritic cells and other subsets of mouse leukocytes Cell. Immunol. 1995, 163 (1) 148-156
6. Witmer-Pack, M. D.; Swiggard, W. J.; Mirza, A.; Inaba, K.; Steinman, R. M. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145 II. Expression in situ in lymphoid and nonlymphoid tissues Cell. Immunol. 1995, 163 (1) 157-162
7. Jian, W.; Swiggard, W. J.; Heufler, C.; Peng, M.; Mirza, A.; Steinman, R. M.; Nussenzweig, M. C. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing Nature 1995, 375 (6527) 151-155
8. Mahnke, K.; Guo, M.; Lee, S.; Sepulveda, H.; Swain, S. L.; Nussenzweig, M.; Steinman, R. M. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments J. Cell Biol. 2000, 151 (3) 673-683
9. Bonifaz, L. C.; Bonnyay, D. P.; Charalambous, A.; Darguste, D. I.; Fujii, S.-I.; Soares, H.; Brimnes, M. K.; Moltedo, B.; Moran, T. M.; Steinman, R. M. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination J. Exp. Med. 2004, 199 (6) 815-824 (Pubitemid 38375201)
10. Wang, W. W.; Das, D.; Tang, X. L.; Budzynski, W.; Suresh, M. R. Antigen targeting to dendritic cells with bispecific antibodies J. Immunol. Methods 2005, 306 (1-2) 80-92 (Pubitemid 41742216)
11. Wang, W. W.; Das, D.; Suresh, M. R. A versatile bifunctional dendritic cell targeting vaccine vector Mol. Pharmaceutics 2009, 6 (1) 158-172
12. Drosten, C.; Günther, S.; Preiser, W.; Van der Werf, S.; Brodt, H. R.; Becker, S.; Rabenau, H.; Panning, M.; Kolesnikova, L.; Fouchier, R. A. M.; Berger, A.; Burguière, A. M.; Cinatl, J.; Eickmann, M.; Escriou, N.; Grywna, K.; Kramme, S.; Manuguerra, J. C.; Müller, S.; Rickerts, V.; Stürmer, M.; Vieth, S.; Klenk, H. D.; Osterhaus, A. D. M. E.; Schmitz, H.; Doerr, H. W. Identification of a novel coronavirus in patients with severe acute respiratory syndrome N. Engl. J. Med. 2003, 348 (20) 1967-1976 (Pubitemid 36569985)
13. Peiris, J. S. M.; Lai, S. T.; Poon, L. L. M.; Guan, Y.; Yam, L. Y. C.; Lim, W.; Nicholls, J.; Yee, W. K. S.; Yan, W. W.; Cheung, M. T.; Cheng, V. C. C.; Chan, K. H.; Tsang, D. N. C.; Yung, R. W. H.; Ng, T. K.; Yuen, K. Y. Coronavirus as a possible cause of severe acute respiratory syndrome Lancet 2003, 361 (9366) 1319-1325 (Pubitemid 36514862)
14. Surjit, M.; Lal, S. K. The SARS-CoV nucleocapsid protein: A protein with multifarious activities Infect. Genet. Evol. 2008, 8 (4) 397-405 (Pubitemid 351682373)
15. Peng, H.; Yang, L. t.; Wang, L. y.; Li, J.; Huang, J.; Lu, Z. q.; Koup, R. A.; Bailer, R. T.; Wu, C. y. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients Virology 2006, 351 (2) 466-475 (Pubitemid 44108066)
16. Rota, P. A.; Oberste, M. S.; Monroe, S. S.; Nix, W. A.; Campagnoli, R.; Icenogle, J. P.; Peñaranda, S.; Bankamp, B.; Maher, K.; Chen, M. H.; Tong, S.; Tamin, A.; Lowe, L.; Frace, M.; DeRisi, J. L.; Chen, Q.; Wang, D.; Erdman, D. D.; Peret, T. C. T.; Burns, C.; Ksiazek, T. G.; Rollin, P. E.; Sanchez, A.; Liffick, S.; Holloway, B.; Limor, J.; McCaustland, K.; Olsen-Rasmussen, M.; Fouchier, R.; Günther, S.; Osterhaus, A. D. H. E.; Drosten, C.; Pallansch, M. A.; Anderson, L. J.; Bellini, W. J. Characterization of a novel coronavirus associated with severe acute respiratory syndrome Science 2003, 300 (5624) 1394-1399 (Pubitemid 36638152)
17. Gupta, V.; Tabiin, T. M.; Sun, K.; Chandrasekaran, A.; Anwar, A.; Yang, K.; Chikhlikar, P.; Salmon, J.; Brusic, V.; Marques, E. T. A.; Kellathur, S. N.; August, T. J. SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens Virology 2006, 347 (1) 127-139
18. Schulze, K.; Staib, C.; Schätzl, H. M.; Ebensen, T.; Erfle, V.; Guzman, C. A. A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus Vaccine 2008, 26 (51) 6678-6684
19. Kim, T. W.; Lee, J. H.; Hung, C. F.; Peng, S.; Roden, R.; Wang, M. C.; Viscidi, R.; Tsai, Y. C.; He, L.; Chen, P. J.; Boyd, D. A. K.; Wu, T. C. Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus J. Virol. 2004, 78 (9) 4638-4645 (Pubitemid 38501085)
20. Zhao, P.; Cao, J.; Zhao, L.-J.; Qin, Z.-L.; Ke, J.-S.; Pan, W.; Ren, H.; Yu, J.-G.; Qi, Z.-T. Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine Virology 2005, 331 (1) 128-135 (Pubitemid 39593638)
21. Zhu, M. S.; Pan, Y.; Chen, H. Q.; Shen, Y.; Wang, X. C.; Sun, Y. J.; Tao, K. H. Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine Immunol. Lett. 2004, 92 (3) 237-243 (Pubitemid 38471964)
22. Kang, M. L.; Cho, C. S.; Yoo, H. S. Application of chitosan microspheres for nasal delivery of vaccines Biotechnol. Adv. 2009, 27 (6) 857-865
23. Mao, H. Q.; Roy, K.; Troung-Le, V. L.; Janes, K. A.; Lin, K. Y.; Wang, Y.; August, J. T.; Leong, K. W. Chitosan-DNA nanoparticles as gene carriers: Synthesis, characterization and transfection efficiency J. Controlled Release 2001, 70 (3) 399-421 (Pubitemid 32155463)
24. Wikstrom, M. E.; Stumbles, P. A. Mouse respiratory tract dendritic cell subsets and the immunological fate of inhaled antigens Immunol. Cell Biol. 2007, 85 (3) 182-188 (Pubitemid 46701431)
25. Kammila, S.; Das, D.; Bhatnagar, P. K.; Sunwoo, H. H.; Zayas-Zamora, G.; King, M.; Suresh, M. R. A rapid point of care immunoswab assay for SARS-CoV detection J. Virol. Methods 2008, 152 (1-2) 77-84
26. Corsi, K.; Chellat, F.; Yahia, L. H.; Fernandes, J. C. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles Biomaterials 2003, 24 (7) 1255-1264 (Pubitemid 36069133)
27. Das, D.; Suresh, M. R. Copious production of SARS-CoV nucleocapsid protein employing codon optimized synthetic gene J. Virol. Methods 2006, 137 (2) 343-346 (Pubitemid 44397168)
28. Wang, W. W. S.; Das, D.; McQuarrie, S. A.; Suresh, M. R. Design of a bifunctional fusion protein for ovarian cancer drug delivery: Single-chain anti-CA125 core-streptavidin fusion protein Eur. J. Pharm. Biopharm. 2007, 65 (3) 398-405
29. Elgueta, R.; Benson, M. J.; De Vries, V. C.; Wasiuk, A.; Guo, Y.; Noelle, R. J. Molecular mechanism and function of CD40/CD40L engagement in the immune system Immunol. Rev. 2009, 229 (1) 152-172
30. Bonifaz, L.; Bonnyay, D.; Mahnke, K.; Rivera, M.; Nussenzweig, M. C.; Steinman, R. M. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance J. Exp. Med. 2002, 196 (12) 1627-1638 (Pubitemid 36026474)
31. Trumpfheller, C.; Finke, J. S.; López, C. B.; Moran, T. M.; Moltedo, B.; Soares, H.; Huang, Y.; Schlesinger, S. J.; Park, C. G.; Nussenzweig, M. C.; Granelli-Piperno, A.; Steinman, R. M. Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine J. Exp. Med. 2006, 203 (3) 607-617
32. Ninomiya, A.; Ogasawara, K.; Kajino, K.; Takada, A.; Kida, H. Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice Vaccine 2002, 20 (25-26) 3123-3129
33. See, R. H.; Zakhartchouk, A. N.; Petric, M.; Lawrence, D. J.; Mok, C. P. Y; Hogan, R. J.; Rowe, T.; Zitzow, L. A.; Karunakaran, K. P.; Hitt, M. M.; Graham, F. L.; Prevec, L.; Mahony, J. B.; Sharon, C.; Auperin, T. C.; Rini, J. M.; Tingle, A. J.; Scheifele, D. W.; Skowronski, D. M.; Patrick, D. M.; Voss, T. G.; Babiuk, L. A.; Gauldie, J.; Roper, R. L.; Brunham, R. C.; Finlay, B. B. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus J. Gen. Virol. 2006, 87 (3) 641-650
34. Roper, R. L.; Rehm, K. E. SARS vaccines: Where are we? Expert Rev. Vaccines 2009, 8 (7) 887-898
35. Kutzler, M. A.; Weiner, D. B. Developing DNA vaccines that call to dendritic cells J. Clin. Invest. 2004, 114 (9) 1241-1244 (Pubitemid 40385294)
36. Kutzler, M. A.; Weiner, D. B. DNA vaccines: Ready for prime time? Nat. Rev. Genet. 2008, 9 (10) 776-788
37. Wang, D.; Christopher, M. E.; Nagata, L. P.; Zabielski, M. A.; Li, H.; Wong, J. P.; Samuel, J. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses J. Clin. Virol. 2004, 31 (Suppl. 1) S99-S106
38. Garg, N. K.; Mangal, S.; Khambete, H.; Sharma, P. K.; Tyagi, R. K. Mucosal delivery of vaccines: Role of mucoadhesive/biodegradable polymers Recent Pat. Drug Delivery Formulation 2010, 4 (2) 114-128
39. Csaba, N.; Garcia-Fuentes, M.; Alonso, M. J. Nanoparticles for nasal vaccination Adv. Drug Delivery Rev. 2009, 61 (2) 140-157
40. Yeh, T.-H.; Hsu, L.-W.; Tseng, M. T.; Lee, P.-L.; Sonjae, K.; Ho, Y.-C.; Sung, H.-W. Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening Biomaterials 2011, 32 (26) 6164-6173
41. Jiang, H. L.; Kang, M. L.; Quan, J. S.; Kang, S. G.; Akaike, T.; Yoo, H. S.; Cho, C. S. The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization Biomaterials 2008, 29 (12) 1931-1939
42. Khatri, K.; Goyal, A. K.; Gupta, P. N.; Mishra, N.; Vyas, S. P. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B Int. J. Pharm. 2008, 354 (1-2) 235-241
43. Xu, J.; Dai, W.; Wang, Z.; Chen, B.; Li, Z.; Fan, X. Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen A protects mice against nasopharyngeal colonization by streptococcus pneumoniae Clin. Vaccine Immunol. 2011, 18 (1) 75-81